Andrew E. Clark

2.7k total citations · 1 hit paper
35 papers, 1.3k citations indexed

About

Andrew E. Clark is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Andrew E. Clark has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 11 papers in Epidemiology and 10 papers in Clinical Biochemistry. Recurrent topics in Andrew E. Clark's work include Bacterial Identification and Susceptibility Testing (10 papers), Antibiotic Resistance in Bacteria (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Andrew E. Clark is often cited by papers focused on Bacterial Identification and Susceptibility Testing (10 papers), Antibiotic Resistance in Bacteria (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Andrew E. Clark collaborates with scholars based in United States, Canada and United Kingdom. Andrew E. Clark's co-authors include Donna M. Wolk, Erin Kaleta, Amit Arora, Michael Mallozzi, Gayatri Vedantam, V. K. Viswanathan, Jacques Schrenzel, Abdessalam Cherkaoui, Vicki H. Wysocki and Ravi Sarode and has published in prestigious journals such as Gastroenterology, Clinical Microbiology Reviews and Diabetes.

In The Last Decade

Andrew E. Clark

33 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry: a Fundamental Shift in the Routine Practice of Clinical Microbiology

2013 614 citations Andrew E. Clark, Erin Kaleta et al. Clinical Microbiology Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew E. Clark United States	12	584	489	406	282	159	35	1.3k
Hossein Salimnia United States	21	395 0.7×	632 1.3×	539 1.3×	300 1.1×	174 1.1×	79	1.6k
Erin Kaleta United States	11	590 1.0×	255 0.5×	367 0.9×	247 0.9×	171 1.1×	24	1.1k
Elizabeth Palavecino United States	22	312 0.5×	529 1.1×	472 1.2×	210 0.7×	169 1.1×	89	1.4k
Eui-Chong Kim South Korea	18	349 0.6×	447 0.9×	407 1.0×	240 0.9×	112 0.7×	39	1.1k
Felicia Ruffin United States	22	447 0.8×	692 1.4×	448 1.1×	255 0.9×	280 1.8×	71	1.4k
Christopher D. Doern United States	20	355 0.6×	649 1.3×	586 1.4×	241 0.9×	447 2.8×	41	1.5k
Olivier Dauwalder France	26	490 0.8×	1.1k 2.2×	407 1.0×	635 2.3×	321 2.0×	73	1.7k
Emmanuelle Bille France	22	637 1.1×	294 0.6×	765 1.9×	445 1.6×	206 1.3×	55	1.8k
Reiner Schaumann Germany	20	337 0.6×	319 0.7×	314 0.8×	191 0.7×	207 1.3×	54	1.1k
Paul D. Stamper United States	16	569 1.0×	584 1.2×	530 1.3×	135 0.5×	207 1.3×	28	1.0k

Countries citing papers authored by Andrew E. Clark

Since Specialization

Citations

This map shows the geographic impact of Andrew E. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Clark more than expected).

Fields of papers citing papers by Andrew E. Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew E. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Clark. The network helps show where Andrew E. Clark may publish in the future.

Co-authorship network of co-authors of Andrew E. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew E. Clark. A scholar is included among the top collaborators of Andrew E. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew E. Clark. Andrew E. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bobenchik, April M., Robin R. Chamberland, Andrew E. Clark, et al.. (2025). Activity of novel ceftibuten-avibactam, ceftazidime-avibactam, and comparators against a challenge set of Enterobacterales from outpatient centers and nursing homes across the United States (2022–2024). Antimicrobial Agents and Chemotherapy. 69(5). e0186724–e0186724. 1 indexed citations

Clark, Andrew E., et al.. (2025). Reactive infectious mucocutaneous eruption: an increasingly encountered complication during periods of increased Mycoplasma pneumoniae transmission—a case report. PubMed. 1(6).

Scudder, Christopher, Melissa Ly, Harry S. Porterfield, et al.. (2025). Comparative phenotypic and genotypic antimicrobial susceptibility surveillance in Achromobacter spp. through whole genome sequencing. Microbiology Spectrum. 13(4). e0252724–e0252724. 3 indexed citations

Clark, Andrew E., Ji-Woong Kim, Christine Pybus, et al.. (2024). Antibiotic resistance genotype, phenotype, and clinical outcomes in patients with Gram-negative infections at Rabin Medical Center in Israel. Microbiology Spectrum. 13(1). e0038324–e0038324.

Asempa, Tomefa E., April M. Bobenchik, Lori Bourassa, et al.. (2023). Antimicrobial Activity of Tebipenem and Comparators against Enterobacterales from diverse Outpatient Centers and Nursing Homes in the United States. International Journal of Antimicrobial Agents. 61(3). 106733–106733. 5 indexed citations

Monogue, Marguerite L., James M. Sanders, Christine Pybus, et al.. (2023). Ceftolozane/tazobactam heteroresistance in cystic fibrosis-relatedPseudomonas aeruginosainfections. JAC-Antimicrobial Resistance. 5(4). dlad083–dlad083. 3 indexed citations

Clark, Andrew E., Zhaohui Wang, Huiyu Yao, et al.. (2022). Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern. Clinical Chemistry. 68(8). 1042–1052. 12 indexed citations

Kim, Jiwoong, Christine Pybus, Richard J Medford, et al.. (2022). Clinically undetected polyclonal heteroresistance among Pseudomonas aeruginosa isolated from cystic fibrosis respiratory specimens. Journal of Antimicrobial Chemotherapy. 77(12). 3321–3330. 2 indexed citations

Clark, Andrew E., et al.. (2022). The Alternative Sigma Factor SigL Influences Clostridioides difficile Toxin Production, Sporulation, and Cell Surface Properties. Frontiers in Microbiology. 13. 871152–871152. 7 indexed citations

10.

Clark, Andrew E., Madhusudhanan Narasimhan, Lenin Mahimainathan, et al.. (2022). SARS-CoV-2 coinfections with variant genomic lineages identified by multiplex fragment analysis. Frontiers in Genetics. 13. 942713–942713. 3 indexed citations

11.

Narasimhan, Madhusudhanan, Lenin Mahimainathan, Ellen Araj, et al.. (2021). Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups. Journal of Clinical Microbiology. 59(7). e0038821–e0038821. 80 indexed citations

12.

SoRelle, Jeffrey A., Lenin Mahimainathan, Dominick Cavuoti, et al.. (2020). Saliva for use with a point of care assay for the rapid diagnosis of COVID-19. Clinica Chimica Acta. 510. 685–686. 19 indexed citations

13.

Clark, Andrew E., et al.. (2020). Home versus indoor trampoline park injuries: A four-year review of hospital admissions, associated costs, and impact on patients. Trauma Case Reports. 31. 100385–100385. 1 indexed citations

14.

Gould, Odette N., et al.. (2018). Total Knee Arthroplasty Communication Checklist Increases Patient Satisfaction. The Journal of Arthroplasty. 34(3). 456–461. 9 indexed citations

15.

Vedantam, Gayatri, Michael Mallozzi, Jennifer Lising Roxas, et al.. (2018). An Engineered Synthetic Biologic Protects Against Clostridium difficile Infection. Frontiers in Microbiology. 9. 2080–2080. 21 indexed citations

16.

Vedantam, Gayatri, et al.. (2016). Mo1676 Flagellar Glycosylation Influences Motility, Flagellar Assembly, and Toxin Production in Clostridium difficile. Gastroenterology. 150(4). S749–S749. 1 indexed citations

17.

Hernandez, Diana R., Duane W. Newton, Nathan A. Ledeboer, et al.. (2015). Multicenter Evaluation of MRSASelectII Chromogenic Agar for Identification of Methicillin-Resistant Staphylococcus aureus from Wound and Nasal Specimens. Journal of Clinical Microbiology. 54(2). 305–311. 9 indexed citations

18.

Clark, Andrew E., Erin Kaleta, Amit Arora, & Donna M. Wolk. (2013). Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry: a Fundamental Shift in the Routine Practice of Clinical Microbiology. Clinical Microbiology Reviews. 26(3). 547–603. 614 indexed citations breakdown →

19.

Clark, Andrew E., et al.. (2012). Molecular Characterization of Invasive Staphylococcus aureus Infection in Central New York Children: Importance of Two Clonal Groups and Inconsistent Presence of Selected Virulence Determinants. Journal of the Pediatric Infectious Diseases Society. 2(1). 30–39. 8 indexed citations

20.

Gloyn, Anna L., Manishi Desai, Andrew E. Clark, et al.. (2002). Human calcium/calmodulin-dependent protein kinase II gamma gene (CAMK2G): cloning, genomic structure and detection of variants in subjects with Type II diabetes. Diabetologia. 45(4). 580–583. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact